Filing Details

Accession Number:
0001127602-22-025746
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-16 16:13:37
Reporting Period:
2022-11-14
Accepted Time:
2022-11-16 16:13:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1520262 Alkermes Plc. ALKS Pharmaceutical Preparations (2834) 981007018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1837109 Jr. Angelo David Daglio Connaught House
1 Burlington Road
Dublin 4 Ireland
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2022-11-14 35,000 $23.31 80,000 No 4 P Indirect By the Daglio Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By the Daglio Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 10,724 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $22.82 to $23.57. Full information regarding the number of shares purchased at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.
  2. Shares are held by The David A Daglio Jr Trust U/A 09/21/17 (the "Daglio Trust"), of which the reporting person is both sole trustee and sole beneficiary.